中文 | English
Return
Total: 4 , 1/1
Show Home Prev Next End page: GO
MeSH:(Immunoglobulin Light-chain Amyloidosis/drug therapy*)

1.Oral melphalan plus high-dose dexamethasone as first-line therapy for patients with primary light chain amyloidosis.

Cong Li ZHANG ; Kai Ni SHEN ; Jun FENG ; Xin Xin CAO ; Yue Ying MAO ; Lu ZHANG ; Wei SU ; Dao Bin ZHOU ; Jian LI

Chinese Journal of Hematology 2018;39(8):641-644

2.Efficacy and safety of daratumumab in the treatment of advanced light chain amyloidosis.

Kai Ni SHEN ; Hui Lei MIAO ; Ya Juan GAO ; Xin Xin CAO ; Dao Bin ZHOU ; Wei SU ; Jian LI

Chinese Journal of Hematology 2022;43(1):31-34

3.Curative effect observation of patients with primary systemic amyloidosis treated by the combination of bortezomib with dexamethasone and cyclophosphamide.

Jin LU ; Hui WANG ; Xiao-jun HUANG

Chinese Journal of Hematology 2013;34(4):345-348

4.Clinical investigation of primary amyloidosis with autologous hematopoietic stem cell transplantation.

Zhi-xiang QIU ; Mang-ju WANG ; Li-hong WANG ; Yu-hua SUN ; Wei-lin XU ; Wei LIU ; Jin-ping OU ; Yu-jun DONG ; Wen-sheng WANG ; Yuan LI ; Yue YIN ; Ze-yin LIANG ; Xi-nan CEN ; Han-yun REN

Chinese Journal of Hematology 2012;33(3):187-190

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4 , 1/1 Show Home Prev Next End page: GO